Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.

Journal of drugs in dermatology : JDD

Volumn 3, Issue 4, 2004, Pages 367-373

  Jarratt, Michael ^a   Breneman, Debra ^a   Gottlieb, Alice B ^a   Poulin, Yves ^a   Liu, Yin ^a   Foley, Valerie ^a  

^a DermResearch Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CLOBETASOL; COSMETIC;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS; CLOBETASOL; DOUBLE-BLIND METHOD; FEMALE; HAIR PREPARATIONS; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SCALP DERMATOSES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 16544372355     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)